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Summary DNA copy number changes were compared in 29 histologically benign follicular adenomas, of which five were atypical, and 13
follicular carcinomas of the thyroid by comparative genomic hybridization. DNA copy number changes were frequent in adenomas (14 out of
29, 48%). Most changes were gains, and they always invotved a gain of the entire chromosome 7 (10 out of 29, 34%); other common gains
involved chromosomes 5 (28%). 9 (10%), 12 (24%), 14 (21%), 17 (17%), 18 (14%) and X (17%). Losses were found only in four (14%)
adenomas. Two of the five atypical adenomas had DNA copy number losses, and none had gains. Unlike adenomas, gains were rare and
losses were frequent in carcinomas. A loss of chromosome 22 or 22q was particularly common in carcinomas (6 out of 13, 46%), whereas a
loss of chromosome 22 was found in only two (7%) adenomas, one of which was atypical (P= 0.002). A loss of 1p was also frequent in
carcinomas (31o%), but gains of chromosomes 5, 7, 12, 14 or X that were common in adenomas were not found. Loss of chromosome 22 or
22q was present in six of the eight widely invasive follicular carcinomas, but in only one of the five minimally invasive carcinomas. We
conclude that large DNA copy number changes are common in thyroid adenomas. These changes are strikingly different from those found in
follicular carcinomas consisting of few losses and frequent gains, especially those of chromosome 7. A loss of chromosome 22 is common in
widely invasive follicular carcinoma.
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Follicular adenoma is the most common thvroid tumour. It is
defined as an encapsulated benign tumour showing, follicular cell
differentiation (Hedmg,er et al. 1988). Despite the fact that follic-
ular adenomas are benign neoplasms and do not gix-e rise to metas-
tases. one quarter of them are DNA aneuploid by flow cytometry
(Joensuu et al. 1988). and clonal chromosome abnormalities have
been found in karvotype analvses (Bondeson et al. 1989: Tevssier
et al. 1990: v-an den Berg et al. 1990: Sozzi et al. 1992: Antonini et
al. 1993: Roque et al. 1993a: Belge et al. 1994: Criado et al. 1995).
One-third of follicular adenomas have been reported to harbour
either numerical chromosomal abnormalities or rearrangyements
that are mainlx balanced (Sozzi et al. 1992). Trisomies of several
chromosomes. including 5. 7. 12. 14. 18. 20 and 22 have been
described in karyotype analyses (Antonini et al. 1993: Heim et al.
1995). Most frequent are trisomies of chromosomes 5. 7 and 12.
detected in about 20%7 of adenomas w-ith an abnormal karvotvpe
(Heim et al. 1995). Van den Berg et al (1990) suggested that a
combination of numerical abnormalities. including a gain ofchro-
mosomes 4. 5. 7. 9. 12 or 16. is characteristic of follicular
adenoma. In addition to follicular adenoma. nodular goitre has
also shown trisomies in the same chromosomes as follicular
adenoma (Roque et al. 1993b). indicating a close relationship
between some types of nodularhy-perplasia and adenoma.
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Follicular carcinoma is the second most common type of thyroid
carcinoma after papillary carcinoma It is much less common than
follicular adenoma. which is diatnosed about ten times as often as
follicular carcinoma Cvtogenetic information about follicular carci-
noma is limited, and only a few tumours hax-e been examined
(Bondeson et al. 1989: Jenkins et al. 1990: Tevssier et al. 1990:
Herrman et al. 1991: van den Berg et al. 1991: Roque et al. 1993c:
Grebe et al. 1997). The short arm ofchromosome 3 has been reported
to contain rearrangements. and a minimal common deleted region of
3p25-pter has been described (Herrman et al. 1991: Roque et al.
1993c). Van den Berg et al ( 1991 ) reported idic(22:22 p l:pll ) and
additional structural abnormalities in chromosome 22 in a case of
follicular carcinoma. and Jenkins et al ( 1990) reported aberrations
that were mainly deletions in three cases.
Some follicular adenomas may has-e a close morphological
resemblance to follicular carcinoma: the main difference is the
presence of invasion of tumour into the capsular blood vessels in
carcinoma. Because of this resemblance. a question arises whether
follicular carcinoma originates from a pre-existin- adenoma
(Franssila 1997). Follicular adenoma might represent a precan-
cerous lesion that could transform into carcinoma through copy
number chanaes in critical aenes controlling mx asion and affecting,
metastasis formation. In the present study. we used comparative
gyenomic hybridization (CGH) to study DNA copy number changes
in follicular thyroid tumours. To our knowledgye. these tumours
have not been studied by this method earlier. The results show- that.
although DNA copy number changes can frequently be detected in
both types of thyroid neoplasms. the chancges differ greatly.
suggesting that. in spite of similar morphology. different cenetic
mechanisms may give rise to these neoplasms.
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MATERIALS AND METHODS
Tumour specimens and DNA isolation
The series consists of 29 follicular adenomas and 13 follicular
carcinomas of the thyroid. stored in the frozen tissue bank of
Department of Pathology. Helsinki University Central Hospital.
Finland (Table 1). Twenty-four (83%c) of the patients with an
adenoma and ten (77%7 ) ofthose ith a carcinoma were women. In
follicular adenoma. the median age at diagnosis was 46 years
(range 25-87) and in follicular carcinoma 71 years (range 34-85).
All origainal histological diagnoses were re-examined (KY) without
knowledge ofthe CGH results. The classification used w-as that of
WHO (Hedinger et al. 1989).
The tissue samples had been frozen in liquid nitrogen upon
arrixal at the Department of Pathology. and stored at -80'C until
analyvsis. Frozen sections were cut. stained with toluidine blue and
examined to verifx- that the tissue examined contained mainly
tumour tissue. In all cases. at least 70%7 of the cells analysed were
tumour cells. Twenty to thirty 5-im sections were cut from each
tumour specimen. and genomic DNA was isolated usinc a
standard phenol-based method (Sambrook et al. 1989).
Comparative genomic hybridization (CGH)
CGH w-as performed according to the method of Kallioniemi et al
(1994) with some modifications. and according to the protocol
descrnbed by El-Rifai et al (1997). Tumour DNA was labelled with
fluorescein-dUTP and fluorescein-dC(TP (Dupont. Boston. MA.
USA). and the normal reference DNA (extracted from the blood of a
healthy man or woman) w-as labelled w-ith Texas red-dUTP and
Texas red-dCTP (Dupont) in a standard nick translation reaction.
Equal amounts (1 ji) ofthe labelled test and reference probes were
used for hybridization. ith 10 jig ofunlabelled human Cot- 1 DNA
to block the binding of repetitive sequences in 10 jil of the
hybridization buffer [50% formamide. 10%c dextran sulphate. 2 x
SSC (1 x SSC is 0.15 -x sodium chlonrde. 0.015 N sodium citrate.
pH 7)]. The DNA was then denatured for 5 min at 75°C before
applying it to normal lymphocyte preparations. Before hybridiza-
tion. the metaphase preparations were dehydrated in a series of 70.
80 and 1001% ethanol concentrations and denatured at 65CC for
2 min in a formamide solution (70% fornamide/2 x SSC). The
slides were then dehydrated on ice as described above. Then they
were treated with proteinase-K at 37°C for 7.5 min (0.2 jg ml-' in
20 mnLi Tris-HCl. 2 m-i calcium chlonrde. pH 7). and once again
dehydrated in a senres of nising ethanol concentrations as indicated
above. Hvbridization was performed in a moist chamber at 37C for
48 h. Post-hybridization washes were as follow's: three times in 50%
formamide/2 x SSC/pH 7. twice in 2 x SSC. and once in 0.1 x SSC
at 45CC followed by 2 x SSC and 0.1 xI sodium dihydrogen phos-
phatelO. 1 mI disodium hydrogen phosphatelO. 1%c Nonidet P40/pH 8
and distilled water at room temperature for 10 min each. The slides
were counterstained with 4'.6-diamidino-2-phenylindole (DAPI) at
a concentration of0.1 jIg ml-' in an anti-fade solution.
Table 1 Clinical characteristcs and CGH findings of 29 follicular adenomas
and 13 follhcular carcinomas of the thyroid
Case Age/ Subtype CGH resuItsa
no. Sex
1 64/F
2 77/F
3 59/F
4 35/F
5 56/F
6 34/F
7 37/F
8 58/F
9 47/F
10 43/F
11 25/F
12 47/F
13 47/F
14 49/F
15 36/F
16 41/F
17 43/M
18 76/F
19 54/M
20 41/M
21 46/F
Adenoma
Adenoma
Adenoma (oxyphilic)
Adenoma
Adenoma (oxyphilic)
Adenoma
Adenoma (oxyphilic)
Adenoma
Adenoma
Adenoma
Adenoma
Adenoma
Adenoma
Adenoma
Adenoma
Adenoma (oxyphilic)
Adenoma
Adenoma
Adenoma
Adenoma
Adenoma
22 43/F Adenoma
23 44/F Adenoma
24 73/F Adenoma
25 26/F Adenoma (atypical)
26 39/M Adenoma (atypical)
27 46/F Adenoma (atypical)
28 48/F Adenoma (atypical)
29 87/F Adenoma (atypical)
30 34/F Carcinoma
(minimally invasive)
31 78/F Carcinoma
(minimally invasive)
32 66/F Carcinoma
(minimally invasive)
33 53/M Carcinoma
(minimally invasive)
34 57/F Carcinoma
(minimally invasive)
35 50/M Carcinoma
(widely invasive)
36 76/M Carcinoma
(widely invasive)
37 77/F Carcinoma
(widely invasive)
38 81/F Carcinoma
(widety invasive)
39 71/F Carcinoma
(widely invasive)
40 79/F Carcinoma
(widety invasive)
41 85/F Carcinoma
(widely invasive)
42 68/F Carcinoma
(widety invasive)
+4.+5.+X.+7.+9,+12.+14q12-qter.
+16.+17,+22ql2.1 --qter
Normal
+5pl4-pter.+5q23.1 --qter.+7
+5.+X.+7.+9.+12.+14q12-qter.+16.
+17.+18,+20,+21 q21.3--qter
+5.+7.+10,+13.+14.+17,+18
Normal
Normal
+3.+5,+X.+7.+12.+18
Normal
+5p14-pter,+5q23--qter.+7.+12
+X.+7,+9.+12.+14q13-qter.+17
+5.+7,+12.+14q21 --qter
-3
Normal
Normal
+7
Normal
Normal
Normal
Normal
+3.+5.+X.+7.+12.+13.+14.
+16.+17.+18.+19.+20
-22
Normal
Normal
-22
-1-2-6-9-11.-13
Normal
Normal
Normal
Normal
Normal
+17q. -22q12.3-qter
+17q
Normal
+1q22-qter.-1 p21-22
-13.-22
-22
+1q22-qter.-1 p.-22
Normal
-22
-1p13-23.-21.-22
+1q24-ter.-1p.-9.-13.-18.-22
aGains of the DNA sequences are marked with + and losses with -.
Digital image analysis
The hybridizations were analy-sed using an Olympus fluorescence
microscope and an ISIS digital image analysis svstem
(Metasystem. Altlussheim. Germanv) based on an integrated
hiah-sensitivity monochrome CCD camera and automated CGH
anals sis software. The three-colour images with red. green and
blue were acquired from 8-10 metaphases. Only metaphases of
0ood quality with strong uniform hybridization were included in
the analysis. Chromosomes not suitable for CGH were excluded
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Figure 1 Mean red-green rabo profiles of selected chromosomes reflecting DNA sequence copy number changes in follicular adenoma and follicular
carcinoma. Profiles are those of chromosones 5.7, 12, 14 (follicular adenoma) and 1, 22 (follicularcarcinomna), which showed the most frequent genetic
changes. The line in the middle of the profile indicates the base line ratio (1.0), the left and the right lines indicate ratio values of 0.85 and 1.17 respectively. Left:
The profiles represent the following aberrations: loss of 1p and gain of 1q (case no. 42), gain of entire chromosome 5 (case no. 8), gain of entire chromosome 7
(case no. 21), gain of entire chromosome 12 (case no. 8), gain of 14q12f-qter (case no. 1) and loss of entire chromosome 22 (case no. 42). Right: The profiles
of chroxosomes with no aberrations obtained from varnus negative control expenments
from the analysis (e.g. chromosomes that wvere heavilv bent or
overlapping or those that had oxerlying artefacts). Chromosomal
regions were interpreted as amplified (a gain) when the red-green
ratio exceeded 1.17: as highly amplified. when the ratio exceeded
1.5: and underrepresented (a loss) when the ratio was less than
0.85 (Figure 1). All findings were confirmed using a confidence
interval of 99%7. A positive control with known chromosomal
aberrations and a negatix e control were included in each
hvbridization to xerifx the reliabilitv ofthe method. Chromosomal
regions in the centromenrc areas of chromosomes 1. 9. 16 and Y
and the p-arms of acrocentric chromosomes were discarded from
the analysis because oftheir large heterochromatic areas.
As CGH recognizes only proportional changes in DNA copy
number. the ratio profiles do not indicate the absolute copy number
changes. In diploid and near-diploid cells. a ratio of 1.5 indicates a
100%7 increase in the copy number in a chromosome arm or in an
area of the size of a chromosome band (Knuutila et al. 1998). If
this threshold is not reached the increase is only 50%7. suggesting
chromosomal trisomy.
Statistical analysis
Fisher's exact test w-as used in statistical analysis. All P-x-alues are
two-tailed.
RESULTS
A summary ofall gains and losses detected is shown in Table 1 and
Figure 2. As many as 14 (48%7c) of the 29 follicular adenomas had
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DNA copy number changes. Only nine (13%e ) of the total of 72
chances found in adenomas xere losses. and thev occurred only in
four (14%7c) adenomas. whereas gains wxere found in ten (35%7c)
adenomas. On axerage. there wxere 2.5 changes per adenoma
(median 1: range 0-12(. A gain in DNA sequences occurred in 16
different chromosomes. and a gain of a whole chromosome was
-erv common (74%7c of all changes). probably related to trisomv of
chromosomes 3.4. 5. 7. 9. 10. 12. 13. 14. 16. 17. 18. 19. 20 and X.
The most frequently involxved chromosomes in follicular
adenoma Axere 7 (ten cases: 34%- > and 5 (eight cases: 28%/).
Particularly. a gain of the entire chromosome 7 was present in all
ten adenomas that displayed one or more gains. The other chromo-
somes commonly gained were 12 (sexen cases: 24%). 14 (six
cases: 21%9). X (fixe cases: 17%/-c). 17 (fixe cases: 17%/,r). 18 (four
cases: 14%7) and 9 (three cases: 10%). In four cases. the onlx
changes were a loss of an entire chromosome or chromosomes.
These losses wxere in chromosomes 1. 2. 6. 11. 13 (case 26). 3 (case
13) and 22 (cases 22 and 25). Txxo of these four follicular
adenomas x-ith a loss (nos. 25 and 26) xxere histologicallN classi-
fied as atypical adenomas. A DNA copy number gain was not
found in any ofthe fixve atypical follicular adenomas.
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Follicular carcinomas displayed copy number changes in 9 (69% c
out ofthe 13 cases analysed. On axerage. there xxere 1.6 changes per
case (median 1: range 0-6). and the number of changres detected
among the 13 cases was 21. Unlike adenomas. losses xxere more
common than gains (16 X s. 5). and the frequency of tumours with a
loss (8 out of 13. 62%7c) w-as greater than in adenomas (4 out of 29.
14%e. P = 0.003). Aberrations xxere detected in eirht different chro-
mosomes: 1. 9. 13. 17. 18. 19. 21 and 22. Chromosome 22 was most
frequentlx involved, and it was deleted in as manx as six (46%-) carci-
nomas. Fixe ofthese six tumours showed a loss ofthe wxhole chromo-
some 22. and in one case there x-as a loss of the chromosome arm
22q12.3-qter. Loss ofchromosome 22 or22q was present in six ofthe
eight widelx ixasix-e folhicularcarcinomas. butonly in one ofthe fi e
minimalix invasixe carcinomas. In adenomas. a loss ofchromosome
22 xxas found only in txo (7%c) tumours (P=0.002). one of xxhich
was an atypical adenoma A loss of lp. lp21-22 and lpl3-23 xas
detected in fourcarcinomas (cases 35. 38. 41 and42). In addition. loss
ofthe wxholechromosome 9. 18 or 19 A-ere eachdetected in one carci-
noma. andchromosome 13 in txwo carcinomas. Again xx-as foundonly
in four chromosomes. lq22-qter (cases 35. 38). lq24-qter (case 42)
and the long arm ofchromosome 17 (cases 32. 33 .
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Figure 2 A summary of gains and losses in follicular adenomas and carcinomas. The gains are shown on the right side of the chromosomes. and the losses
on the left. Each line represents a gained or lost region in a single tumour. The gains and losses found in the follicular adenomas are marked with solid lines.
and those in follicular carcinomas with dotted lines
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No highly amplified chromosomal regions were detected either
in follicular adenoma or carcinoma. None of the carcinomas had
aberrations in chromosome 7. w-hich wvas gained in 10 out ofthe 29
adenomas (P = 0.02). and no gains were found in chromosomes 5.
12. 14 or X. which were also frequently gained in adenomas. There
were only four losses that were found both in adenomas and carci-
nomas. They were found in chromosomes 1 (one adenoma and
four carcinomas). 9 (one adenoma and one carcinoma). 13 (one
adenoma and two carcinomas) and 22 (two adenomas and seven
carcinomas). The only gain that was found in both types of
tumours w-as that of chromosome 17q (five adenomas and two
carcinomas).
DISCUSSION
We found DNA copy number changes to be frequent in follicular
thyroid adenomas. Typical aberrations were gains of the entire
chromosomes 5. X. 7. 12. 14. 17 and 18. Our results are in line
with results ofkarvotvpe studies in which numerical chromosomal
abnormalities. mainly trisomies. and especially trisomies of chro-
mosomes 5. 7 and 12. have been described (Antonini et al. 1993:
Belge et al. 1994: Heim et al. 1995). In a fluorescence in situ
hybridization study. not only one extra copy but also several extra
copies of chromosomes 7 and 12 were reported (Criado et al.
1995). Our CGH data did not. however. suggest several extra
copies in these chromosomes. as high DNA copy number changes
were not detected (see Materials and methods. section Digital
image analysis).
In follicular carcinoma. DNA copy number losses were
commonly found. A typical aberration was deletion of a part of or
the entire chromosome 22. which was found in about one-half of
all carcinomas. It appeared to be more frequent in widely invasive
than in minimally invasive carcinomas. which suggests that this
deletion mav be associated with malignant progression of follic-
ularcarcinoma. Further studies are needed to find out ifdeletion of
chromosome 22 is correlated to survival.
Also in karyotvpe studies. deletions have been found in follic-
ular carcinomas (Jenkins et al. 1990). A monosomy or DNA copy
number loss of chromosome 22 is not unique to follicular thyroid
carcinomas as it has been described in other types of human
neoplasms such as meningioma. glioma. mesothelioma and
gastrointestinal stromal tumour (Tonk et al. 1992: Mohapatra et al.
1995: El-Rifai et al. 1996: Bjorqkvist et al. 1997). The long, arm of
chromosome 22 contains the tumour suppressor gene neurofibro-
matosis type 2 (NF2) at 22q12 (Ruttledge et al. 1994). but there is
also evidence for the presence of another putative tumour
suppressor gene distal to NF2 (Schofield et al. 1996). The signifi-
cance of these and other suppressor genes located in 22q in the
genesis offollicular thyroid carcinoma is unsettled.
Although the CGH profiles of most folhcular adenomas and
carcinomas differed greatly from each other. in four follicular
adenomas the only aberration detected was a loss ofan entire chro-
mosome or chromosomes. and in two of them the lost chromo-
some w-as 22. Of the five atypical adenomas. losses w-ere found in
two. and in one ofthem chromosome 22 had been lost. These find-
ings might suggest that some follicular adenomas. including the
atypical adenoma. may have a common genetic origin with foflic-
ular carcinoma. Atypical adenoma is not a well-defined entity. but
rather a tumour that shows architectural and cytological features
resembling those seen in follicular carcinoma. It. however. lacks
invasion, the most important criterion of follicular carcinoma. In
earlier studies. a subgroup of follicular carcinoma called follicular
carcinoma without invasion was described (Woolner et al. 1961).
These tumours were associated with excellent prognosis and
would probably be called atypical adenomas at present.
In conclusion. the results indicate that in follicular thyroid
adenomas extensive chromosomal changes are often present. and
that these changes are mainly gains ofentire chromosomes. Unlike
adenomas. gains are not frequent in follicular carcinoma. whereas
losses. especially those ofchromosome 22 or 22q. are found often.
Loss of chromosome 22 maxv be associated with the widely
invasive type offollicular carcinoma.
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